Long-Acting Injectables Curb Schizophrenia Readmission

Patients with schizophrenia discharged on an LAI antipsychotic had significantly lower 30-day psychiatric readmission rates than those sent home with an oral antipsychotic.
Medscape Medical News

source https://www.medscape.com/viewarticle/long-acting-injectable-antipsychotics-reduce-schizophrenia-2024a10002nf?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?